Clinical trial
Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients
NCT02795065 is registered in ClinicalTrials.gov with Mohamed Sayed Mohamed Abbas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients
- Lead sponsor
- Mohamed Sayed Mohamed Abbas
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- March 31, 2016
- Enrollment
- 100 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.